Study With Oral Isovue in Abdominopelvic CT

  • STATUS
    Recruiting
  • participants needed
    218
  • sponsor
    Bracco Diagnostics, Inc
Send
Updated on 19 February 2024
See if I qualify

Summary

This is a retrospective clinical study with prospectively designed blinded evaluation of CT images in adult and pediatric patients who underwent CT examinations of the abdomen and pelvis and were orally administered a solution of Isovue-300 to opacify the GI tract to distinguish it from adjacent abdominal and pelvic structures. The study will collect already existing data, such as demographic data, adverse events and CT images, for all chronologically enrolled patients who meet the inclusion/exclusion criteria prospectively defined in this protocol

Details
Condition Patients Requiring Abdominopelvic CT With Oral Administration of Contrast
Age 100years or below
Treatment Iopamidol
Clinical Study IdentifierNCT04453059
SponsorBracco Diagnostics, Inc
Last Modified on19 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

b'Patients will be included in the study if:'
b'Demographic and safety data are available for analysis'
b'Complete set of CT images performed after oral administration of Isovue-300 are'
b'available for assessment'
b'Isovue-300 was orally administered during an interval time of 60-20 minutes before the'
b'CT scanning.'
b'Patients will be excluded from the study if:'
b'Oral contrast agent received within 1 week prior to the CT scan'
b'Undergone any abdominopelvic surgery procedure that resulted in alteration of the'
b'bowel transit time prior to the CT exam'
b'CT exam with oral administration of Isovue was performed because of a known or'
b'uspected condition of bowel obstruction'
b'Patient did not actively drink the contrast solution.'
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.